Biomaric P24 Elisa Kit
HIV1 p24 antibody (IgG purified) |
|||
| 20-000702 | Fitzgerald | 100 ug | EUR 266 |
|
Description: Sheep polyclonal HIV1 p24 antibody (IgG purified) |
|||
×
Human IgG antibody Laboratories manufactures the biomaric p24 elisa kit reagents distributed by Genprice. The Biomaric P24 Elisa Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact p24 Antigen Elisa. Other Biomaric products are available in stock. Specificity: Biomaric Category: P24 Group: Elisa Kit
Human True insulin ELISA Kit |
||
| MyBiosource | 5x96-Strip-Wells-(Competitive) | EUR 3020 |
Human True insulin ELISA Kit |
||
| MyBiosource | 96-Strip-Wells-(Competitive) | EUR 690 |
Human True insulin ELISA Kit |
||
| MyBiosource | 96-Strip-Wells-(Sandwich) | EUR 690 |
HIV1 p24 antibody (IgG purified) |
||
| Fitzgerald | 100 ug | EUR 266 |
|
Description: Sheep polyclonal HIV1 p24 antibody (IgG purified) |
||
HIV1 p24 antibody (IgG purified) |
||
| MyBiosource | 0.1mg | EUR 410 |
HIV1 p24 antibody (IgG purified) |
||
| MyBiosource | 5x0.1mg | EUR 1635 |
Human True insulin (TI) ELISA Kit |
||
| SAB | 96Т | EUR 799 |
×
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
|||
| BNUB2430-500 | Biotium | 1uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 1mg/mL |
|||
| BNUM2570-50 | Biotium | 1uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL |
|||
| BNUB2570-100 | Biotium | 1uL | EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL |
|||
| BNUB2570-500 | Biotium | 1uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL |
|||
| BNCB2430-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL |
|||
| BNCB2430-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL |
|||
| BNCB2570-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL |
|||
| BNCB2570-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381198-002mgWithBSAAzideat02mgmL | MyBiosource | 0.02mg(WithBSA&Azideat0.2mg/mL) | EUR 230 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381198-01mgWithBSAAzideat02mgmL | MyBiosource | 0.1mg(WithBSA&Azideat0.2mg/mL) | EUR 405 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381198-01mgWithoutBSAAzideat1mgmL | MyBiosource | 0.1mg(WithoutBSA&Azideat1mg/mL) | EUR 405 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381198-5x01mgWithBSAAzideat02mgmL | MyBiosource | 5x0.1mg(WithBSA&Azideat0.2mg/mL) | EUR 1725 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381198-5x01mgWithoutBSAAzideat1mgmL | MyBiosource | 5x0.1mg(WithoutBSA&Azideat1mg/mL) | EUR 1725 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381199-002mgWithBSAAzideat02mgmL | MyBiosource | 0.02mg(WithBSA&Azideat0.2mg/mL) | EUR 230 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381199-01mgWithBSAAzideat02mgmL | MyBiosource | 0.1mg(WithBSA&Azideat0.2mg/mL) | EUR 405 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381199-01mgWithoutBSAAzideat1mgmL | MyBiosource | 0.1mg(WithoutBSA&Azideat1mg/mL) | EUR 405 |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) |
|||
| MBS4381199-5x01mgWithBSAAzideat02mgmL | MyBiosource | 5x0.1mg(WithBSA&Azideat0.2mg/mL) | EUR 1725 |
×